Bamco Inc. NY Reduces Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Bamco Inc. NY reduced its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 288,747 shares of the medical instruments supplier’s stock after selling 5,857 shares during the period. Mettler-Toledo International comprises 1.2% of Bamco Inc. NY’s portfolio, making the stock its 17th largest position. Bamco Inc. NY owned 1.37% of Mettler-Toledo International worth $433,034,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. EverSource Wealth Advisors LLC grew its stake in Mettler-Toledo International by 8.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 7 shares in the last quarter. UMB Bank n.a. grew its position in shares of Mettler-Toledo International by 6.6% during the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock worth $158,000 after buying an additional 7 shares in the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of Mettler-Toledo International by 7.2% in the second quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock worth $166,000 after buying an additional 8 shares during the last quarter. DT Investment Partners LLC raised its holdings in Mettler-Toledo International by 13.3% in the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after acquiring an additional 8 shares in the last quarter. Finally, Suncoast Equity Management boosted its stake in Mettler-Toledo International by 2.0% during the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock valued at $690,000 after acquiring an additional 9 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Trading Up 0.6 %

Shares of Mettler-Toledo International stock opened at $1,251.20 on Monday. The stock has a market capitalization of $26.40 billion, a price-to-earnings ratio of 33.73, a PEG ratio of 4.13 and a beta of 1.16. Mettler-Toledo International Inc. has a twelve month low of $1,068.33 and a twelve month high of $1,546.93. The business’s 50 day simple moving average is $1,345.17 and its 200-day simple moving average is $1,392.37.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Sell-side analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on MTD shares. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. increased their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Wells Fargo & Company dropped their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average price target of $1,338.75.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.